<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PubTator</source><date>2020-12-04</date><key>BioC.key</key>
<document><id>28368423</id><passage><infon key="type">title</infon><offset>0</offset><text>Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.</text><annotation id="0"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="0" length="3"/><text>Myc</text></annotation><annotation id="1"><infon key="code">555</infon><infon key="NCBI Gene identifier">16019</infon><infon key="type">STARGENE</infon><location offset="13" length="15"/><text>B-cell receptor</text></annotation><annotation id="2"><infon key="NCBI Gene identifier">12229</infon><infon key="type">STARGENE</infon><location offset="89" length="3"/><text>Btk</text></annotation></passage><passage><infon key="type">abstract</infon><offset>105</offset><text>Dysregulation of the oncogenic transcription factor MYC induces B-cell transformation and is a driver for B-cell non-Hodgkin lymphoma (B-NHL). MYC overexpression in B-NHL is associated with more aggressive phenotypes and poor prognosis. Although genomic studies suggest a link between MYC overexpression and B-cell receptor (BCR) signaling molecules in B-NHL, signaling pathways essential to Myc-mediated B-cell transformation have not been fully elucidated. We utilized intracellular phospho-flow cytometry to investigate the relationship between Myc and BCR signaling in pre-malignant B cells. Utilizing the Eμ-myc mouse model, where Myc is overexpressed specifically in B cells, both basal and stimulated BCR signaling were increased in precancerous B lymphocytes from Eμ-myc mice compared with wild-type littermates. B cells overexpressing Myc displayed constitutively higher levels of activated CD79α, Btk, Plcγ2 and Erk1/2. Notably, Myc-overexpressing B cells maintained elevated BCR signaling despite treatment with ibrutinib, a Bruton's tyrosine kinase inhibitor. Furthermore, PI3K/Akt pathway signaling was also increased in Eμ-myc B cells, and this increase was partially suppressed with ibrutinib. In addition, experiments with Btk-null B cells revealed off-target effects of ibrutinib on BCR signaling. Our data show that in pre-malignant B cells, Myc overexpression is sufficient to activate BCR and PI3K/Akt signaling pathways and further enhances signaling following BCR ligation. Therefore, our results indicate that precancerous B cells have already acquired enhanced survival and growth capabilities before transformation, and that elevated MYC levels confer resistance to pharmacologic inhibitors of BCR signaling, which has significant implications for B-NHL treatment.</text><annotation id="3"><infon key="code">000</infon><infon key="NCBI Gene identifier">17869</infon><infon key="type">Gene</infon><location offset="157" length="3"/><text>MYC</text></annotation><annotation id="4"><infon key="code">000</infon><infon key="NCBI Gene identifier">17869</infon><infon key="type">Gene</infon><location offset="248" length="3"/><text>MYC</text></annotation><annotation id="5"><infon key="code">000</infon><infon key="NCBI Gene identifier">17869</infon><infon key="type">Gene</infon><location offset="390" length="3"/><text>MYC</text></annotation><annotation id="6"><infon key="code">555</infon><infon key="NCBI Gene identifier">16019</infon><infon key="type">Gene</infon><location offset="413" length="15"/><text>B-cell receptor</text></annotation><annotation id="7"><infon key="code">555</infon><infon key="NCBI Gene identifier">16019</infon><infon key="type">Gene</infon><location offset="430" length="3"/><text>BCR</text></annotation><annotation id="8"><infon key="code">000</infon><infon key="NCBI Gene identifier">17869</infon><infon key="type">Gene</infon><location offset="497" length="3"/><text>Myc</text></annotation><annotation id="9"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="653" length="3"/><text>Myc</text></annotation><annotation id="10"><infon key="code">555</infon><infon key="NCBI Gene identifier">16019</infon><infon key="type">STARGENE</infon><location offset="661" length="3"/><text>BCR</text></annotation><annotation id="11"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="718" length="3"/><text>myc</text></annotation><annotation id="12"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="741" length="3"/><text>Myc</text></annotation><annotation id="13"><infon key="code">555</infon><infon key="NCBI Gene identifier">16019</infon><infon key="type">STARGENE</infon><location offset="813" length="3"/><text>BCR</text></annotation><annotation id="14"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="880" length="3"/><text>myc</text></annotation><annotation id="15"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="949" length="3"/><text>Myc</text></annotation><annotation id="16"><infon key="NCBI Gene identifier">12518</infon><infon key="type">Gene</infon><location offset="1005" length="5"/><text>CD79α</text></annotation><annotation id="17"><infon key="NCBI Gene identifier">12229</infon><infon key="type">STARGENE</infon><location offset="1012" length="3"/><text>Btk</text></annotation><annotation id="18"><infon key="NCBI Gene identifier">234779</infon><infon key="type">Gene</infon><location offset="1017" length="5"/><text>Plcγ2</text></annotation><annotation id="19"><infon key="NCBI Gene identifier">26417;26413</infon><infon key="type">Gene</infon><location offset="1027" length="6"/><text>Erk1/2</text></annotation><annotation id="20"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="1044" length="3"/><text>Myc</text></annotation><annotation id="21"><infon key="code">555</infon><infon key="NCBI Gene identifier">16019</infon><infon key="type">STARGENE</infon><location offset="1091" length="3"/><text>BCR</text></annotation><annotation id="22"><infon key="NCBI Gene identifier">12229</infon><infon key="type">STARGENE</infon><location offset="1141" length="24"/><text>Bruton's tyrosine kinase</text></annotation><annotation id="23"><infon key="NCBI Gene identifier">18708</infon><infon key="type">Gene</infon><location offset="1190" length="4"/><text>PI3K</text></annotation><annotation id="24"><infon key="NCBI Gene identifier">11651</infon><infon key="type">Gene</infon><location offset="1195" length="3"/><text>Akt</text></annotation><annotation id="25"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="1242" length="3"/><text>myc</text></annotation><annotation id="26"><infon key="NCBI Gene identifier">12229</infon><infon key="type">STARGENE</infon><location offset="1344" length="3"/><text>Btk</text></annotation><annotation id="27"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="1465" length="3"/><text>Myc</text></annotation><annotation id="28"><infon key="code">555</infon><infon key="NCBI Gene identifier">16019</infon><infon key="type">STARGENE</infon><location offset="1510" length="3"/><text>BCR</text></annotation><annotation id="29"><infon key="code">333</infon><infon key="NCBI Gene identifier">18708</infon><infon key="type">Gene</infon><location offset="1518" length="4"/><text>PI3K</text></annotation><annotation id="30"><infon key="NCBI Gene identifier">11651</infon><infon key="type">Gene</infon><location offset="1523" length="3"/><text>Akt</text></annotation><annotation id="31"><infon key="NCBI Gene identifier">17869</infon><infon key="type">GENERIF</infon><location offset="1764" length="3"/><text>MYC</text></annotation><annotation id="32"><infon key="code">555</infon><infon key="NCBI Gene identifier">16019</infon><infon key="type">STARGENE</infon><location offset="1824" length="3"/><text>BCR</text></annotation></passage></document>
</collection>
